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Replication in physiotherapy: useful or reinventing the wheel?
Mark R Elkins
Editor, Journal of PhysiotherapyUndertaking a process that has been performed before can be
useful for several reasons: to see if the results are reproducible
under unchanged conditions, to see if the process still produces the
same result after a prolonged period of time, and to average or
accumulate the results of the repeated process. Replication of other
processes, however, can be unnecessary ‘reinvention of the wheel’.
This editorial discusses several clinical and research processes in
physiotherapy that do or do not beneﬁt from replication, with the
purpose of encouraging physiotherapists to undertake replication
when it is useful and to discourage redundant replication.
Replication in clinical practice
Replication of assessment
Because many clinical physiotherapy treatments are applied
more than once, it is usual to repeat outcome assessments.
Clinicians should remember, however, that such ongoing assess-
ment is a measure of the patient’s progress, not a direct measure of
the treatment’s effect, because the patient’s progress is also
affected by statistical regression, placebo effects and natural
recovery. Nevertheless, repeated assessment is helpful because it
can indicate that: a patient has improved to the point where
further treatment is not required; a patient is progressing very
badly, in which case another therapy might be considered; or
further improvement under the current treatment appears
unlikely.1 When decisions about treatment are made using
ongoing assessments, consideration should also be given to the
patient’s preferences about care and to prognostic information
about the condition.
Another potential role of assessment replication in clinical
practice is the generation of prognostic information for patients
under standard clinical management.2–4 In some countries, this
occurs on a national scale, with a proportion of physiotherapists
routinely documenting clinical outcomes using validated tools to
contribute to a national database.5 For example, in the
Netherlands, the National Information Service for Allied Health
Care (LiPZ) is a longitudinal database that contains data, entered by
physiotherapists, about patients, referrals, diagnoses, treatments
and evaluations.5 However, the quality and completeness of the
data must be rigorously maintained for such datasets to remain
representative enough to be prognostically useful.6
Some clinical assessments, such as medical and social history
taking, may be repeated many times during a hospital admission
by: staff in the emergency department; medical, physiotherapy,
nursing and other staff on the ward; and staff in the subacute and
community settings. Although it may be frustrating for the
physiotherapist and patient to know that the same questionshttp://dx.doi.org/10.1016/j.jphys.2015.07.006
1836-9553/ 2015 Australian Physiotherapy Association. Published by Elsevier B.V. Alare asked many times, some of this repeated assessment may
contribute to greater patient safety.7–9
Replication of intervention
The intensity of a physiotherapy intervention is often pro-
gressed over a series of applications, but some interventions have
cumulative beneﬁt with pure repetition alone, such as repeated
task practice in stroke without progression of the difﬁculty10 or a
static training regimen as part of load management in tendino-
pathy.11 Other interventions have been investigated speciﬁcally for
their efﬁcacy in single versus repeat applications. For example,
benign paroxysmal positional vertigo can be treated using a
physical manoeuvre of the head to reposition particles in the
semicircular canals.12 A trial of single versus repeated applications
of the manoeuvre in a single treatment session showed that when
repeated applications were used, there was a signiﬁcantly greater
likelihood of the patient being symptom free during the following
week.13 Repetition may also reinforce some efforts in health
promotion. For example, repeated advice/education to increase
physical activity in patients with metabolic syndrome is more
effective than a single session.14 Conversely, although a single
occasion of advice/education to increase physical activity has some
beneﬁt for people after stroke,15 reinforcement of this with
repetition does not increase the effect.16 Some interventions have
an effect that lies between these two extremes. For example, when
repeated yearly, pulmonary rehabilitation continues to have short-
term beneﬁts each time it is applied, but this does not seem to
produce cumulative long-term physiological improvement.17
Replication of documents for use in clinical practice
Clinical physiotherapists often get involved in generating
documents intended for use in clinical practice, including: patient
information leaﬂets (eg, aftercare advice for a patient receiving a
forearm cast); protocols for a clinical procedure (eg, sputum
induction in suspected respiratory infection); checklists (eg,
handover information for adolescents with a chronic disease
transferring to an adult clinic); and various other tools and
standards. Although such documents are sometimes published in
journals,18 many are not, so they risk being reinvented at multiple
hospitals or practices. Partly to reduce replication of such
documents among public hospitals, the Agency for Clinical
Innovation (ACI) in New South Wales, Australia, fosters the
development of such documents and makes them freely available
on their website. Such documents should be largely transferrable
to other states in Australia andmany centres overseas so that their
free availability may help physiotherapists to avoid replicating
these documents unnecessarily. Many of these documents wouldl rights reserved.
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Quality Health Service (NSQHS) requirements for accreditation.
Physiotherapists are encouraged to make use of these documents.
One caveat is that it is difﬁcult for any agency the size of ACI to
provide comprehensive and up-to-date coverage of all clinical
areas, particularly with large documents like clinical practice
guidelines for complex conditions. For example, the ACI guideline
on total hip and knee replacement19 was completed in 2012. It
concluded that evidencewas lacking about the determinants of the
outcome of rehabilitation and the relative beneﬁts of various
rehabilitation formats, but data on these topics have already
subsequently been published.20–22 Therefore, sites like ACI may
not be the best place for physiotherapists to search for clinical
practice guidelines. Instead, they could search the PEDro website,
which is a free online searchable database that indexes over
500 clinical practice guidelines relevant to physiotherapy, among
other forms of evidence. In addition, important new guidelines
are summarised in the Appraisal section of Journal of
Physiotherapy. However, the ACI website is a suitable place to
search for protocols and checklists.
Groups like the ACI are not the only organisations to support
this approach of ‘share generously, steal shamelessly – with credit
to the source’. For example, the Royal Children’s Hospital,
Melbourne, places many patient information sheets and other
resources on their website, allowing other paediatric institutions
to use them with acknowledgement of the source. The US Cystic
Fibrosis Foundation also heavily advocates this in their quality
improvement initiatives and has a large online library of
educational materials obtained from many hospitals for open
sharing. Less formally, clinicians could approach colleagues at
neighbouring institutions to share resources. This culture change
towards resource sharing should be encouraged.
Replication in research
Replication of trials
High-quality randomised trials provide unbiased estimates of
physiotherapy treatment effects, but the ﬁndings of a single trial
are often inconclusive. The efﬁcacy of a treatment is usually only
established when a meta-analysis of several trials shows a
statistically signiﬁcant and clinically worthwhile effect. Therefore,
replication of randomised trials is generally seen as important,23 at
least until the treatment is clearly shown to be clinically
worthwhile or not. However, as more replications of a trial
accumulate, the result of a meta-analysis of existing trials may
become highly unlikely to change if another trial is added.24 When
a meta-analysis of existing trials does not provide clear ﬁndings
about whether an intervention has worthwhile effects, and a
further trial is being considered, extended funnel plots can be used
to explore the potential impact of a new trial on the updatedmeta-
analysis.24 This may determine whether a further clinical trial is
justiﬁed.
Replication of systematic reviews
Various justiﬁcations can be put forward for repeating a
systematic review. Sometimes, the preceding review(s) were
methodologically ﬂawed25,26 or did not attempt meta-analysis,
even though it was possible.27,28 Sometimes, the preceding
reviews did not: pool or separate related interventions helpful-
ly,28–32 distinguish the effects in important subgroups of
participants adequately,33 or include all relevant outcomes.34
Another very common reason is that new studies have been
published since the most recent review,35–37 which raises the
question of when it is appropriate to update a review due to new
evidence. Some guides to assessing when a review needs to be
updated have been developed,38–40 although they do not appear to
be widely used – perhaps because simply stating that there is‘some’ new evidence is generally seen as sufﬁcient reason for an
update. Given the exponential accumulation of systematic reviews
of physiotherapy intervention trials,41 some of which only add one
small trial to a large existing cohort, perhaps authors should
consider whether it is worth publishing a systematic review if one
new trial does not appreciably change the clinical implications.
Replication of development of outcome measures
Numerous authors have complained about the proliferation of
outcome measures used to measure the same concept in a
particular clinical population.42–44 For example, the Rehabilitation
Measures Database website lists multiple tools that could be used
to measure the same concept in people with multiple sclerosis:
nine tools that measure gait, nine that measure activities of daily
living, ﬁve that measure quality of life, two that measure dexterity,
and so on. Although theremay be subtle differences between these
measures, there is often redundancy;42–44 therefore, it seemsmore
reasonable for researchers to focus on one core outcome for each
construct. This approach would improve comparability between
studies and allow meta-analyses to report the pooled estimate in
the same units as the original measure. To facilitate this, the Core
Outcome Measures in Effectiveness Trials (COMET) website is a
free searchable online database of consensus documents about
core outcome measures for particular conditions.
Replication of outcome measurement within a study
Although the ﬁnal measurement of participants in a random-
ised trial is often seen as providing the best indication of their
overall outcome, there are advantages to measuring the same
outcome at multiple points during a trial. One advantage is the
opportunity to use longitudinal analyses.45 Instead of analysing the
intervention’s effect at an individual time point, longitudinal
analyses can use data from all time points to estimate the effects at
each time. Furthermore, longitudinal analyses naturally incorpo-
rate outcome data that were measured – perhaps due to patient
unavailability – earlier or later than the measurement point
scheduled in the trial protocol (although to minimise the potential
for bias, researchers should still try to measure at the scheduled
times wherever possible). Finally, longitudinal analyses are partly
protected from bias caused by missing data.45 Analysis of variance
(ANOVA) is one longitudinal method. However, longitudinal
regression models (such as mixed models or generalised estimat-
ing equations) are preferable to ANOVA because they generate
more robust estimates and make fewer assumptions about the
data.46,47 Researchers should carefully consider the number of
assessment points in the study protocol, attempting to generate
rich data without interfering with participants’ willingness to
continue in the study by overburdening them.
Another advantage of frequent repetition of an outcome
measurement is that it generates a detailed picture of the pattern
of changes. For example, in an observational study of the prognosis
of people receiving treatment for a new episode of neck pain,2 daily
measurement of pain severity produced a detailed picture of the
pattern of improvement (Figure 1). It also very precisely identiﬁed
the day on which each participant met the deﬁnition of recovery,
which could then be used to identify predictors of atypical
recovery.2
Validation of predictors
Prognostic studies often identify factors that are predictive of a
particular outcome. However, before these factors are used in
clinical practice, they should undergo validation (ie, replication of
the test of whether they predict the outcome in a second dataset).
There are several ways that this can be achieved.48 A second cohort
could be recruited. Alternatively, a study can be designed so that
the original cohort is randomly split into two groups, with one
group used to identify factor(s) that are predictive in that group
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Figure 1. Clinical course of an episode of recent-onset neck pain. Mean (SE) daily
pain scores (numerical rating scale, 0 to 10) from baseline to day 84 collected from
patient diaries. Modiﬁed from Leaver et al.2
Editorial 171and the other group used to test if the factor(s) are reproducibly
predictive. Bootstrapping methods, which replicate the test of the
putative predictors inmultiple random subsets of one large cohort,
can also be used. Unfortunately, possible predictors are identiﬁed
far more often than they are validated through replication. For
example, in a systematic review of putative predictors of the ﬁrst
episode of low back pain in children, 13 factors were found to be
predictive once, but only four of these had been tested a second
time to determine if their predictive ability was replicable in
another dataset.49
Summary
Whether in clinical practice or research, physiotherapists are
encouraged to use the suggestions in this editorial to avoid
replication where it is redundant, but to embrace it where it offers
worthwhile advantages.
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